The First Mouthful. The palatability challenge in veterinary diets: when what the animal needs to eat and what the animal wants to eat are not quite the same thing.
Somewhere today a nutritionist finishes a formula for a sick cat. Every number on the sheet is right. The phosphorus is where the failing kidney needs it, the protein carefully judged, the mineral and acid-base balance attended to, the energy and essential nutrients accounted for. It is, on paper, a small triumph of veterinary nutrition, a diet that could genuinely slow a disease and lengthen a life. And then it is put down in front of the cat, and the cat looks at it, and walks away.
Nothing on the sheet was wrong. A veterinary diet can be perfectly formulated for the disease and badly formulated for the patient, and the two are not the same achievement.
This is the quiet difficulty at the centre of therapeutic nutrition, and it is a different difficulty from the one an ordinary pet food faces. An everyday food is designed to be wanted, and if the animal wants it, the job is largely done. A veterinary diet is designed to be needed, and being needed is not the same as being wanted. The clinical target and the animal's appetite are set by different authorities that do not consult each other. The kidney has its requirements. The nose has its own. And a diet does not become therapeutic when the nutritionist finishes the formula. It becomes therapeutic when the patient eats it.
So the question this essay begins with is one the analytical sheet cannot answer, and it is worth asking plainly, because so much sophistication rides on it. When what an animal needs to eat and what it wants to eat are not quite the same thing, which of the two decides whether the medicine works?
Movement I
THE COLOURS THE DISEASE REMOVED
To see why this is hard, start with the question each kind of formulator is actually asking, because they are not asking the same one.
The developer of an ordinary pet food asks, broadly, a question of addition. What can I bring forward, or turn up, to make this food more attractive? That formulator is far from unconstrained, since nutrition, safety, processing, cost and regulation all bind the work, but within those bounds there is considerable freedom to chase the palate. The developer of a veterinary diet asks the same question of attraction inside a much narrower clinical corridor. What can I use without compromising what this food is supposed to do? The clinical target comes first and is not negotiable, and the palate has to be satisfied in whatever room is left over. One formulator works on a wide canvas. The other works on a canvas where the disease has already painted, in fixed colours that cannot be moved, and has taken several of the best colours away.
Consider what the constraint actually means. A phosphorus ceiling for a failing kidney is not a preference to be balanced against palatability; it is a wall. A hydrolysed protein selected for an elimination diet cannot simply be swapped for a familiar intact one to improve acceptance, because doing so may defeat the diagnostic or therapeutic purpose the diet exists to serve. The mineral balance a urinary diet must hit is a chemistry the formulation has to deliver, not an aspiration. In each case a lever that an ordinary formulator would reach for without a second thought has been bolted to the floor, and often it is precisely the lever that would most have helped the food be eaten. The disease does not just set the nutritional brief. It confiscates the tools.
The ordinary formulator asks what to add. The veterinary formulator asks what is left.
An earlier Conversation looked hard at the sick animal from the side of measurement, and found that intake is the least trustworthy thing we measure in exactly this patient, because the reliable hunger that lets us read an empty bowl as approval is the first thing many diseases take away. Grant all of that. This essay stands on the other side of the same problem and asks a different question. Not how we misread the sick animal at the bowl, but how we formulate for it at the bench, knowing the appetite we are formulating for may already be compromised before the food is ever set down. The measurement problem and the formulation problem are two faces of one difficulty, and this is the second face.
Which is why the challenge cannot be met by the reflex the phrase invites. Told that veterinary diets are hard to make palatable, everyone reaches for the same answer, that we should simply make them more palatable, work harder at the acceptance, push the appeal. That is not wrong, but it is not sufficient, and it may not always even be the right aim. So before we ask how to make a therapeutic diet more palatable, a prior question is worth sitting with. What, exactly, has each disease forbidden, and how differently does each one break the quiet agreement between what an animal needs and what it wants?
Movement II
FOUR WAYS TO BREAK THE AGREEMENT
Between what an animal needs and what it wants there is, most of the time, a quiet agreement. Fresh meat is both nourishing and delicious; the food that keeps the animal alive is the food it enjoys, and evolution arranged the overlap on purpose. Therapeutic diets are the places where that agreement breaks, and it is worth seeing that it breaks in four quite different ways, because the difference is the whole subtlety.
The renal diet breaks it by subtraction. To slow a failing kidney the formulation restricts phosphorus, the protein quantity and quality have to be judged carefully, and the rest of the formulation is built around maintaining adequate nutrition inside those limits. Each of those judgements is a clinical necessity, and several of them remove or constrain something the palate was using. The diet is asked to be appealing with several of appeal's usual instruments taken out of its hands, and it is asked to be so for an animal whose illness has often dulled its appetite before the bowl is even filled. Need and want here are not in conflict so much as starved of common ground.
The elimination diet breaks the agreement more sharply, almost cruelly. Its whole purpose is to feed a protein the immune system cannot recognise, either one the animal has never met or one hydrolysed into fragments less likely to retain the antigenic structures that provoke the reaction, so that the source of an allergy can be found or managed. Now consider the ordinary formulator's instinct, which is to reach for a familiar, savoury animal protein and the flavour systems built around it. Many of those the elimination diet simply cannot admit, because the familiar ingredient is the very kind of thing the trial exists to exclude. The most convenient tools of acceptance are ruled out by the diagnosis itself. And hydrolysis, which solves the immunological problem, does so only by creating a new sensory one, since the same cutting that hides the protein from the immune system can, as an earlier Conversation followed in detail, expose a bitterness the tongue reads all too well. The diet has to win acceptance with much of the usual toolkit closed to it, and with a process that can work against the palate even as it serves the diagnosis.
The most convenient tools of acceptance are the ones the diagnosis rules out.
The urinary diet breaks it in yet another way, by making the animal's own consumption the delivery mechanism. The point of the diet is to alter the urinary environment, through mineral composition, urine concentration and, where appropriate, urine pH, so that conditions become less favourable to the particular crystal or stone at issue. And that altered environment only reaches the bladder through what the animal actually eats and drinks. A urinary formula that is perfect on the specification sheet and left in the bowl protects nothing. Here need and want are welded together in an uncomfortable way, because the therapeutic effect is not delivered by the formula at all. It is delivered by the eating.
And then there is the obesity diet, which breaks the agreement most interestingly of all, by reversing the goal. Every diet so far wanted the animal to eat and struggled to make that happen. The weight-management diet needs the animal to be nourished and satisfied on fewer calories, and its whole purpose is undone if the result is simply that the animal eats more. The food still has to be palatable enough to be accepted, because a refused diet helps no one. But acceptance is not the same as maximum consumption, and here, for once, the therapeutic objective is plainly not to make the animal eat as much as it possibly can. Which forces the question the whole essay has been circling toward. If one therapeutic diet succeeds by being eaten more and another succeeds by being eaten less, can the aim of veterinary palatability really be, as we so easily assume, simply to make the animal eat as much as possible?
Movement III
MORE IS NOT THE ANSWER
The obesity diet exposed something the other three had kept hidden, which is that we had been assuming, without quite saying so, that the aim of palatability is to make the animal eat as much as possible. For an ordinary palatability test that assumption can pass unnoticed. For a therapeutic diet it cannot, and the moment we notice this, the comfortable instruction to make veterinary diets more palatable begins to dissolve into a more careful set of questions.
Start with the plainest one. Should we always maximise palatability? Put like that the answer is obviously no, because we have just seen a diet whose success depends on the animal not eating to excess. But the point is larger than the single awkward case of obesity, because it exposes a simplification that runs quietly through much of palatability science, the reflexive equation of more eaten with better. More eaten is not always better. Sometimes it is beside the point, sometimes it is the very thing to be avoided, and even where more is genuinely wanted, the amount consumed and the pleasure taken are not the same measurement wearing two names.
More eaten is not always better. Sometimes it is precisely the thing to avoid.
It helps here to separate two ideas that ordinary language runs together. Preference is a comparison, a statement that an animal, offered a choice, leans toward one food over another. Adequate voluntary intake is something else entirely, the plain question of whether the animal, on its own and over time, eats enough of the one diet in front of it to receive the nutrition that diet was built to deliver. A food can win a preference test handsomely and still not be eaten in sufficient quantity, day after day, by a sick animal with a wavering appetite, and it is the second measure, not the first, that decides whether a therapy works. The preferred food and the adequately eaten food are not guaranteed to be the same food.
So the real design objective for a veterinary diet is not the one the reflex proposes. It is not maximum intake, which can be wrong. It is not maximum preference, which can mislead. It is something more disciplined and harder to hit, something close to reliable voluntary intake, sufficient to deliver the intended nutrition, without defeating the therapeutic purpose of the diet. Every clause in that sentence is load-bearing. Reliable, because a good day is not enough for a chronic disease. Sufficient, because the target is a quantity, not a verdict. And without defeating the purpose, because for at least one important class of patient, an over-eaten diet is a failed one.
There is a distinction underneath all of this that the field too often collapses into a single word, and it is worth pulling apart into the three separate things it really is. The first is nutritional adequacy, whether the food, on paper and in the bag, provides the nutrient profile the patient needs. The second is palatability, whether the animal accepts the food and will voluntarily consume it. The third is therapeutic performance, whether enough of that particular nutritional intervention is actually eaten, over enough time, to move the clinical outcome it was designed to move. These are usually spoken of as if the first quietly guarantees the last. It does not. A diet can be nutritionally impeccable and poorly eaten, or readily eaten and clinically beside the point, and only when all three hold together does the sophistication on the specification sheet become medicine in the animal. One does not guarantee the next.
Adequate on paper. Accepted at the bowl. Effective in the patient. Three different questions, and only the animal joins them.
Which leaves a question this essay will pose but not pretend to settle, because it is genuinely open and belongs to the whole field rather than to any one formulator. If the objective for a therapeutic diet is not maximum intake and not maximum preference but something more particular, then should a veterinary diet be judged by the same palatability endpoints as an everyday maintenance food at all? We measure both, at the moment, in much the same way, and usually in healthy animals. There is a proof-of-concept trial that makes the difficulty vivid without meaning to. A commercial renal diet was assessed for acceptance and preference in a group of healthy cats, and it performed respectably, no less palatable overall than the ordinary foods it was tested against. The authors drew an appropriately cautious conclusion: their findings suggest that acceptance of the diet by cats with kidney disease may depend more on clinical status than on the palatability of the food itself. Which is exactly the point. A palatability test in a healthy animal answers one question well and a different question hardly at all.
Are we testing the palatability of the food, or the palatability of the food to the patient?
Movement IV
THE FIRST MOUTHFUL
There is one more thing the specification sheet cannot hold, and it may be the most important of all. A diet is not eaten in the abstract. It is eaten by a particular animal, at a particular moment, and the moment matters as much as the food.
We are tempted to speak of a food as though palatability were a fixed property of it, as though a diet were simply palatable or unpalatable the way it is high or low in phosphorus. But an animal does not meet a food the way an instrument meets a sample. It arrives carrying a physiological state, a history of what it has eaten and how that turned out, and a memory, and for the therapeutic patient every one of those is likely to be working against the meal. The food designed for the sick animal very often first meets that animal on one of the worst eating days of its life, at the moment of diagnosis, when it feels least like eating, and is asked at that exact moment to accept something unfamiliar. This is why refusal at the bowl is not one problem but several wearing the same face. Sometimes the patient is rejecting the food itself. Sometimes it is rejecting the memory of what happened the last time it ate, a nausea the food has been unluckily paired with. And sometimes it is not rejecting the food at all, but is simply too unwell to want to eat anything. Those are three different problems, and clinical guidance is right to insist that the medical causes of a poor appetite be addressed before the food is blamed for it. Palatability, seen this way, is not a number stamped on the food. It is what happens in the meeting between a food in a particular state and an animal in a particular state, and the sick animal brings the harder half of that meeting.
Palatability does not reside in the food alone. It happens between this food and this animal, on this day.
So return, at the end, to the cat we began with, and to the perfect formula it walked away from. Notice what has and has not changed. The formulation has not changed. The analytical sheet, with every number in its place, has not changed. The disease has not changed. All the nutritional sophistication that could slow that cat's illness is still sitting in the bowl exactly as designed. Only one thing stands between that sophistication and the patient it was built for, and it is not a molecule, and it is not on any sheet. It is whether the cat eats.
We have spent a great deal of veterinary nutrition, and a great deal of real ingenuity, on the first half of a sentence, asking what the sick animal should eat. It may be time to give equal seriousness to the second half, which is quieter and less flattering to our chemistry, and asks only whether the sick animal will eat it. The first half is a question of knowledge. The second is a question of acceptance, and acceptance is where the knowledge either reaches the patient or fails to.
Because for the animal in front of the bowl, the old opposition dissolves. Eat to live and live to eat were never really opposites here. The eating is not a reward that follows the therapy or a pleasure separate from it. The eating is the therapy's first and non-negotiable step, the point at which everything the formulation knows either enters the animal or does not. A therapeutic diet left in the bowl cannot deliver the therapy it contains.
The treatment begins with the first mouthful.
References
1. Elliott, J., Rawlings, J.M., Markwell, P.J. & Barber, P.J. (2000). Survival of cats with naturally occurring chronic renal failure: effect of dietary management. Journal of Small Animal Practice 41(6):235-242. doi:10.1111/j.1748-5827.2000.tb03932.x
2. Magalhães, T.R., Corbee, R.J., Queiroga, F.L. & Lourenço, A.L. (2026). Acceptance and preference of a commercial dry renal diet in healthy cats: an in-home proof-of-concept trial. Journal of Animal Physiology and Animal Nutrition. doi:10.1111/jpn.70043
3. Ilias, N., Zaki, A.H.H., Awang Junaidi, A.H., Lau, S.F., Saufi, I. & Ajat, M. (2022). Palatability assessment of prescribed diets on domestic shorthair cats. Veterinary World 15(3):640-646. doi:10.14202/vetworld.2022.640-646
4. Magalhães, T.R., Lourenço, A.L., Corbee, R.J. & Queiroga, F.L. (2023). Clinical management of feline chronic kidney disease in Portugal: a questionnaire-based study. Journal of Feline Medicine and Surgery 25(11):1098612X231206125. doi:10.1177/1098612X231206125
5. Weber, M., Bissot, T., Servet, E., Sergheraert, R., Biourge, V. & German, A.J. (2007). A high-protein, high-fiber diet designed for weight loss improves satiety in dogs. Journal of Veterinary Internal Medicine 21(6):1203-1208. doi:10.1111/j.1939-1676.2007.tb01939.x
6. Berridge, K.C. & Robinson, T.E. (2016). Liking, wanting, and the incentive-sensitization theory of addiction. American Psychologist 71(8):670-679. doi:10.1037/amp0000059
7. van der Vyver, Y., Paul, A., Blecker, C. & Danthine, S. (2026). Gaps and controversies in feline food palatability. Animals 16(17):2721. doi:10.3390/ani16172721
About the Author
Dr. rer. nat. habil. Dr. Seronei Chelulei Cheison is the founder and Chief Executive Officer of Sinonin Biotech GmbH, where he works with petfood companies on palatant sourcing strategies, the innovation of palatability enhancers, and the design of palatability assessment. A trained food enzymologist, he led alternative protein and palatant development at Mars Petcare before founding Sinonin, and his research on protein chemistry spans two decades, a doctorate from Jiangnan University, and a habilitation from the Technical University of Munich.
Sinonin Biotech GmbH is a partner in the ZEST project (Grant Agreement No. 101157382) and the PROSCALE project (Grant Agreement No. 101288362), both funded by the Circular Bio-based Europe Joint Undertaking (CBE JU) under the European Union's Horizon Europe research and innovation programme. Views and opinions expressed are those of the author only and do not necessarily reflect those of the European Union or CBE JU. Neither the European Union nor the granting authority can be held responsible for them.